Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.

Autor: Hakgor A; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Dursun A; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Kahraman BC; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Yazar A; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Savur U; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Akhundova A; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Olgun FE; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey., Arman ME; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey.; Depatment of Internal Medicine, Ascension St. Vincent Hospital, Indianapolis, Indiana, USA., Boztosun B; Depatment of Cardiology, Medipol Mega University Hospital, Istanbul, Turkey.
Jazyk: angličtina
Zdroj: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2024 Apr; Vol. 103 (5), pp. 782-791. Date of Electronic Publication: 2024 Feb 28.
DOI: 10.1002/ccd.31000
Abstrakt: Background: Pulmonary hypertension (PH) and right ventricular dysfunction are poor prognostic predictors in patients underwent transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS).
Aims: The prognostic impact of the main pulmonary artery/ascending aorta diameter ratio (MPA/AOr), measured simply by computed-tomographic angiography (CTA), was investigated in this patient group.
Methods: A total of 374 retrospectively evaluated patients (mean age 78.1 ± 8.4 years, 192 [51.3%] females) who underwent TAVI for severe AS were included. MPA/AOr was measured on preprocedural CTA in all patients and the effect of this measurement on the presence of PH, in-hospital and 2-year-overall long-term mortality was investigated.
Results: The presence of PH was defined as a systolic pulmonary artery pressure (sPAP) >42 mmHg measured by echocardiography. According to multivariate-logistic-regression analysis, MPA/AOr (adjusted [Adj] odds ratio [OR]: 1.188, confidence interval [CI] 95% [1.002-1.410], p = 0.048), tricuspid annular plane systolic excursion (TAPSE) (adj OR:0.736, CI 95% [0.663-0.816], p < 0.001) and left atrial diameter (adj OR:1.051, CI 95% [1.007-1.098], p = 0.024) were identified as independent predictors of PH. In addition, a statistically significant correlation was found between MPA/AOr and TAPSE (r: -0.283, p < 0.001). Furthermore, MPA/AOr was found to be an independent predictor of both in-hospital (adj OR:1.434, CI 95% [1.093-1.881], p = 0.009) and 2-year long-term (adj OR:1.518, CI 95% [1.243-1.853], p < 0.001) mortality in multivariate analysis including TAPSE, STS score and sPAP. In the 2-year Kaplan-Meier survival probability analysis, an MPA/AOr >0.86 was found to have a hazard ratio of 3.697 (95% CI: 2.341-5.840), with a log-rank p < 0.001.
Conclusion: MPA/AOr, which can be measured simply by CTA, may be useful as an indicator of the presence of PH and poor prognosis in patients planned for TAVI for severe AS.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: